Core Viewpoint - China Ping An (601318) reported strong financial performance for the year 2025, with significant growth in profits and shareholder returns [1] Financial Performance - The operating profit attributable to shareholders reached 134.415 billion RMB, a year-on-year increase of 10.3% [1] - The net profit attributable to shareholders after deducting non-recurring items was 143.773 billion RMB, reflecting a year-on-year growth of 22.5% [1] - Shareholder equity surpassed 1 trillion RMB for the first time, reaching 1,000.419 billion RMB, an increase of 7.7% from the beginning of the year [1] Business Growth - The life and health insurance segments maintained high growth, with new business value at 36.897 billion RMB, up 29.3% year-on-year, achieving double-digit growth for three consecutive years [1] Shareholder Returns - The company proposed a final dividend of 1.75 RMB per share for 2025, with a total annual dividend of 2.70 RMB per share, marking a 5.9% increase year-on-year [1] - Total cash dividends amounted to 48.891 billion RMB, continuing a 14-year trend of increases [1] Investment Performance - As of the end of 2025, the investment portfolio of Ping An Insurance reached 6.49 trillion RMB, a growth of 13.2% from the beginning of the year [1] - The comprehensive investment return rate was 6.3%, up 0.5 percentage points year-on-year [1] - The average net investment return rate over the past 10 years was 4.8%, while the average comprehensive investment return rate was 4.9%, exceeding the long-term investment return assumptions [1]

Group 1 - The company announced a proposed cash dividend of 1.75 RMB per share for the fiscal year ending 2025 [1][2] - The total cash dividend for the year is set at 2.70 RMB per share, representing a year-on-year increase of 5.9% [1][2] - The total cash dividend amount is 48.891 billion RMB, with a cash dividend payout ratio based on net operating profit of 36.4% [1][2]

Core Viewpoint - China Ping An reported strong overall performance for the year 2025, with operating profit returning to double-digit growth and exceeding market expectations [1] Financial Performance - Operating profit attributable to shareholders reached 134.415 billion RMB, a year-on-year increase of 10.3% [1] - Net profit attributable to shareholders, excluding non-recurring items, was 143.773 billion RMB, up 22.5% year-on-year [1] - Shareholders' equity surpassed 1 trillion RMB for the first time, reaching 1,000.419 billion RMB, a growth of 7.7% from the beginning of the year [1] - Proposed final dividend for 2025 is 1.75 RMB per share, with a total annual dividend of 2.70 RMB per share, reflecting a year-on-year increase of 5.9% [1] - Total cash dividends amount to 48.891 billion RMB, marking 14 consecutive years of increases [1] - Comprehensive investment return rate was 6.3% [1] Business Growth - Life and health insurance segments maintained high growth, with new business value reaching 36.897 billion RMB, a year-on-year increase of 29.3%, achieving double-digit growth for three consecutive years [1] - New business value from the agent channel grew by 10.4% year-on-year, while per capita new business value increased by 17.2% [1] - New business value from the bancassurance channel saw a significant increase of 138.0% year-on-year [1]

Core Insights - The company reported a return to double-digit growth in operating profit for the year 2025, with a year-on-year increase of 10.3% to 134.415 billion RMB [1] - The net profit attributable to the parent company, excluding non-recurring items, reached 143.773 billion RMB, reflecting a year-on-year growth of 22.5% [1] - The total equity attributable to the parent company surpassed 1 trillion RMB for the first time, reaching 1,000.419 billion RMB, an increase of 7.7% from the beginning of the year [1] Dividend and Payout - The company proposed a final dividend of 1.75 RMB per share for the year 2025, with an annual cash dividend of 2.70 RMB per share, marking a year-on-year increase of 5.9% [1] - The total cash dividend payout amounted to 48.891 billion RMB, maintaining an upward trend for 14 consecutive years [1] Business Performance - The life and health insurance segments exhibited strong growth, with new business value reaching 36.897 billion RMB, a year-on-year increase of 29.3%, achieving double-digit growth for three consecutive years [1] - The new business value margin was 28.5%, up by 5.8 percentage points year-on-year [1] - The overall strength of distribution channels improved, with new business value from the agent channel growing by 10.4% year-on-year and per capita new business value increasing by 17.2% [1] - The bancassurance channel saw a significant increase in new business value, soaring by 138.0% [1] Service Expansion - The company deepened its "insurance + service" strategy, with over 240,000 customers qualifying for home care services [1] - The high-quality health and wellness community project, "Ping An Zhenyi Nian," has been launched in five cities, with operations already commenced in Shanghai and Shenzhen [1]

Core Viewpoint - China Ping An reported a strong performance for the year 2025, with a significant recovery in operating profit and a notable increase in net profit, exceeding market expectations [1] Financial Performance - The operating profit attributable to the parent company reached 134.415 billion RMB, representing a year-on-year growth of 10.3% [1] - The net profit attributable to the parent company, excluding non-recurring items, was 143.773 billion RMB, showing a year-on-year increase of 22.5% [1] - The equity attributable to shareholders of the parent company surpassed 1 trillion RMB for the first time, reaching 1,000.419 billion RMB, an increase of 7.7% from the beginning of the year [1] - The proposed final dividend for 2025 is 1.75 RMB per share, with a total annual dividend of 2.70 RMB per share, reflecting a year-on-year growth of 5.9% [1] - The total cash dividend amounts to 48.891 billion RMB, marking 14 consecutive years of increases [1] Strategic Developments - The comprehensive financial strategy continues to deepen, with steady growth in customer numbers and average contracts per customer [1] - The number of individual customers reached 251 million, a 3.5% increase from the beginning of the year [1] - The online AI "quick service" portal has effectively converted approximately 90 million active monthly users, leading the industry [1] - The retention rate for customers holding three or more products within the group is 99% [1] Healthcare and Elderly Care Initiatives - The healthcare and elderly care strategy is accelerating, with 100% coverage of partnerships with top 100 hospitals and tertiary hospitals in the country [1] - AI combined with real doctors now covers 100% of individual customers within the group [1] - The one-click payment service is available in 77,000 pharmacies nationwide [1] - Over 240,000 customers have qualified for home care services, effectively driving an increase in customer insurance coverage rates and average premiums [1] - The customer insurance coverage rate for those using healthcare and elderly care services has increased by 4 percentage points [1]

3月26日金融一线消息，中国平安公告，2025年归属于母公司股东的营运利润1344.15亿元，同比增长 10.3%；归属于母公司股东的扣非净利润1437.73亿元，同比增长22.5%；营业收入11403.24亿元，基本 保持稳定；归属于母公司股东权益首次突破万亿，达10004.19亿元，较年初增长7.7%。 责任编辑：李琳琳 3月26日金融一线消息，中国平安公告，2025年归属于母公司股东的营运利润1344.15亿元，同比增长 10.3%；归属于母公司股东的扣非净利润1437.73亿元，同比增长22.5%；营业收入11403.24亿元，基本 保持稳定；归属于母公司股东权益首次突破万亿，达10004.19亿元，较年初增长7.7%。 责任编辑：李琳琳 ...

格隆汇3月26日｜中国平安公布2025年全年业绩。整体经营全面向好，核心指标高值增长，实现归属于 母公司股东的营运利润1,344.15亿元，同比增长10.3%。归属于母公司股东的扣非净利润1,437.73亿元， 同比增长22.5%。归属于母公司股东权益首次突破万亿，达10,004.19亿元，较年初增长7.7%。拟派发 2025年末期股息每股现金人民币1.75元；全年股息每股现金人民币2.70元，同比增长5.9%；现金分红总 额488.91亿元，连续14年保持上涨。保险资金投资组合规模6.49万亿元，较年初增长13.2%；综合投资 收益率6.3%，为近5年最高，同比上升0.5个百分点。寿险及健康险业务新业务价值368.97亿元，同比增 长29.3%，连续三年实现双位数增长。代理人渠道新业务价值同比增长10.4%，人均新业务价值同比增 长17.2%；银保渠道新业务价值同比增长138.0%。产险经营质效"双优"，2025年原保险保费收入同比增 长6.6%；保险服务收入同比增长3.3%。整体综合成本率96.8%，同比优化1.5个百分点，为近5年最优。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立之股份有限公司） 股份代號：2318（港幣櫃台）及82318（人民幣櫃台） （債券證券代號：5131） 截至2025年12月31日止年度的經審計業績公告 中國平安保險（集團）股份有限公司（「平安」或「本公司」）董事會（「董事會」）謹此 宣佈本公司及附屬公司截至2025年12月31日止年度的經審計業績公告。本公告刊 載本公司2025年度報告全文，並符合香港聯合交易所有限公司證券上市規則中有 關年度業績初步公告附載的資料之要求。 本業績公告的中英文版本可在本公司網站( www.pingan.cn )和香港交易及結算所有 限公司（「香港交易所」）網站( www.hkexnews.hk )查閱，本業績公告乃根據國際財 務報告準則編製。本公司2025年度報告預計將於2026年4月下旬前發出予本公司 H股股東，並可於其時在香港交易所的網站( www.hkexnews.hk )及本公司的網站 ...

2025 Annual Results Value Growth and Service Innovation March 2026 Cautionary Statements Regarding Forward-Looking Statements To the extent any statements made in this Report contain information that is not historical, these statements are essentially forward-looking. These forward-looking statements include but are not limited to projections, targets, estimates and business plans that the Company expects or anticipates may or may not occur in the future. Words such as "potential", "estimates", "expects", " ...

Group 1 - US stocks collectively rose overnight, with Chinese concept stocks shining as JD.com increased by 8% [1] - Hong Kong's three major indices opened lower today, with the Hang Seng Index down 0.27%, the Hang Seng China Enterprises Index down 0.41%, and the Hang Seng Tech Index down 0.68% [1] - Technology stocks that surged yesterday afternoon due to news influence mostly declined, with Kuaishou dropping 9.7%, and Tencent, Alibaba, Xiaomi, and Baidu all experiencing declines [1] Group 2 - Semiconductor stocks, lithium battery stocks, and new consumption concept stocks all fell, with CATL opening down nearly 3% again [1] - Oil and gas stocks that had been continuously declining saw some rebound, while biopharmaceutical stocks, insurance stocks, and tea beverage concept stocks were active, with China Ping An rising over 5% [1] Group 3 - Jiangsu Jiajian Technology (02617.HK) was included in the Hang Seng Index series constituent stocks, and CATL was also included in the Hang Seng Index, highlighting the value of "core assets" allocation [1] - There is a strong capital influx into "gold + Hong Kong tech" as the lowest fee gold ETF, Huaxia (518850), has attracted capital for 14 consecutive days, and the Hang Seng Tech Index ETF (513180) has seen over 5.1 billion inflows in the past 20 days [1] - The Hang Seng Tech Index ETF (513180) and the Hang Seng Biopharmaceutical ETF (159892) both rose over 2% amid a bullish sentiment from large short sellers and potential risk-averse demand from Middle Eastern capital [1]